NHS to commission 50 pharmacies to offer RSV vaccinations from September 2024 NHS England will commission 25 pharmacy contractors in NHS Mid and South Essex Integrated Care Board (ICB) and a further 25 in NHS North East Essex ICB to provide the RSV community pharmacy pathfinder service.…
Latest Medicine, Ethics and Practice includes expanded sections on prescribing and valproate safety The 47th edition contains additional information on prescribing and patient safety to reflect the Society’s “ongoing commitment to high standards of professional practice”.…
Royal Pharmaceutical Society Assembly Meeting: July 2024 The summer meeting of the Royal Pharmaceutical Society Assembly focused on the UK Pharmacy Professional Leadership Advisory Board, international strategy and its partnership with Pharmacist Support.…
Pharmacists risk being criminalised in puberty blockers ban, warns RPS The Royal Pharmaceutical Society says the emergency prohibition order for gonadotrophin-releasing hormone may be leading to prescribers “unwittingly breaking the law”.…
Screening for gene variants should be broadened to reduce health inequalities, systematic review concludes Study authors have called for an extension to DPYD genetic testing in the UK, to include variants identified in people with African ancestry.…
Hospital pharmacists to receive 5.5% pay rise Health secretary Wes Streeting said the government has accepted the NHS Pay Review Body’s recommendation to offer a 5.5% increase with effect from 1 April 2024 for all Agenda for Change staff.…
Pharmacy bodies say payment system has left Scottish pharmacies in ‘financial chaos’ Payment shortfalls and delays have followed the introduction of the new data capture validation and pricing process, pharmacy bodies have claimed.…
More than 20,000 inhalers returned since November 2023 through recycling pilot Exclusive: Since its launch in November 2023, 20,400 inhalers have been returned through the ‘Re-Hale’ scheme, which operates across 78 locations in East Kent.…
NICE approves three cystic fibrosis drugs for NHS use The National Institute for Health and Care Excellence has approved three drugs used to treat cystic fibrosis, after its initial decision not to recommend them caused “disappointment, anxiety and concern”.…
NSAID prescribing in high-risk groups is a major source of avoidable harm, study finds The study estimated that the practice could have caused more than 6,000 lost years of good health across England over a ten-year period.…
